RBC Capital Maintains Sector Perform on Moderna, Raises Price Target to $45

Benzinga · 07/07 16:01
RBC Capital analyst Luca Issi maintains Moderna (NASDAQ:MRNA) with a Sector Perform and raises the price target from $38 to $45.